Vascular disorders of the liver

This guideline has been approved by the American Association for the Study of Liver Diseases (AASLD) and represents the position of the association.

[1]  Liang‐Kung Chen,et al.  Hereditary hemorrhagic telangiectasia. , 2020, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed.

[2]  S. Kakar,et al.  Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment? , 2009, Archives of pathology & laboratory medicine.

[3]  M. Abramowicz,et al.  Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia , 2008, Clinical genetics.

[4]  G. Garcia‐Tsao,et al.  Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. , 2008, Seminars in liver disease.

[5]  D. Valla,et al.  Budd-Chiari Syndrome , 2008, Seminars in liver disease.

[6]  S. Chevret,et al.  The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. , 2008, Blood.

[7]  M. Remberger,et al.  A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation , 2008, Bone Marrow Transplantation.

[8]  F. d’Ovidio,et al.  Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs multislice computed tomography study. , 2008, Journal of hepatology.

[9]  Tillmann Krahnke,et al.  Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. , 2008, Blood.

[10]  L. Adams,et al.  Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  V. Vilgrain,et al.  Hepatocellular carcinoma in Budd–Chiari syndrome: characteristics and risk factors , 2008, Gut.

[12]  M. Terol,et al.  Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  P. Thuluvath,et al.  Twenty years of liver transplantation for Budd‐Chiari syndrome: A national registry analysis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  A. Sanyal,et al.  Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis , 2007, The American Journal of Gastroenterology.

[15]  C. Sabbà,et al.  Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers , 2007, Journal of thrombosis and haemostasis : JTH.

[16]  P. Chiusolo,et al.  Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders , 2007, Journal of thrombosis and haemostasis : JTH.

[17]  G. Garcia‐Tsao.  Liver involvement in hereditary hemorrhagic telangiectasia (HHT). , 2007, Journal of hepatology.

[18]  D. Allan,et al.  Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  C. Kitchens,et al.  Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe , 2007, Journal of Thrombosis and Thrombolysis.

[20]  G. Tiscia,et al.  The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.

[21]  P. Mannucci,et al.  Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis , 2006, Hepatology.

[22]  R. Gish,et al.  Model for end‐stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  J. Belghiti,et al.  Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry , 2006, Annals of surgery.

[24]  R. Groszmann,et al.  Expert pediatric opinion on the Report of the Baveno IV Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension , 2006, Pediatric transplantation.

[25]  H. Janssen,et al.  Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. , 2006, Haematologica.

[26]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[27]  V. de Lédinghen,et al.  Aiming at minimal invasiveness as a therapeutic strategy for Budd‐Chiari syndrome , 2006, Hepatology.

[28]  Robert I. White,et al.  Liver involvement in hereditary hemorrhagic telangiectasia: CT and clinical findings do not correlate in symptomatic patients. , 2006, AJR. American journal of roentgenology.

[29]  A. Fennerty.  Venous thromboembolic disease and cancer , 2006, Postgraduate Medical Journal.

[30]  Brian R. Phillips,et al.  Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach , 2006, Clinical Cancer Research.

[31]  E. Tsochatzis,et al.  Pylephlebitis complicating silent diverticulitis , 2006, The Lancet.

[32]  G. Ferraioli,et al.  Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy , 2006, Abdominal Imaging.

[33]  W. Fischbach,et al.  Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab , 2006, Annals of Hematology.

[34]  M. Hashizume,et al.  Consensus on extra‐hepatic portal vein obstruction , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[35]  R. Moineddin,et al.  Portal vein thrombosis in the neonate: risk factors, course, and outcome. , 2006, The Journal of pediatrics.

[36]  D. Valla.  Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage , 2006, Gut.

[37]  Yoshio Watanabe,et al.  Extrahepatic portal vein morphology in children with extrahepatic portal hypertension assessed by 3-dimensional computed tomographic portography: a new etiology of extrahepatic portal hypertension. , 2006, Journal of pediatric surgery.

[38]  J. Klempnauer,et al.  Sinusoidal Obstruction Syndrome of the Liver after Hematopoietic Stem Cell Transplantation: Decision Making for Orthotopic Liver Transplantation , 2006, International journal of hematology.

[39]  À. Rovira,et al.  Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy , 2006, Hepatology.

[40]  K. Togashi,et al.  Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. , 2006, Radiology.

[41]  R. Superina,et al.  Correction of Extrahepatic Portal Vein Thrombosis by the Mesenteric to Left Portal Vein Bypass , 2006, Annals of surgery.

[42]  C. Tinelli,et al.  Contrast-enhanced versus conventional and color Doppler sonography for the detection of thrombosis of the portal and hepatic venous systems. , 2006, AJR. American journal of roentgenology.

[43]  A. Burroughs,et al.  Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. , 2006, Journal of hepatology.

[44]  I. Tleyjeh,et al.  Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis , 2006, Bone Marrow Transplantation.

[45]  E. Cholongitas,et al.  Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation , 2006, Alimentary pharmacology & therapeutics.

[46]  P. Bayrak-Toydemir,et al.  Genotype–phenotype correlation in hereditary hemorrhagic telangiectasia: Mutations and manifestations * , 2006, American journal of medical genetics. Part A.

[47]  J. Bosch,et al.  Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd‐Chiari syndrome , 2006, Hepatology.

[48]  E. Kuipers,et al.  Pathogenesis and Treatment of Budd-Chiari Syndrome Combined with Portal Vein Thrombosis , 2006, The American Journal of Gastroenterology.

[49]  G. Mufti,et al.  Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. , 2005, Gastroenterology.

[50]  J. Guenther,et al.  Deciphering Mesenteric Venous Thrombosis: Imaging and Treatment , 2005, Vascular and endovascular surgery.

[51]  M. Khuroo,et al.  Budd–Chiari syndrome: Long‐term effect on outcome with transjugular intrahepatic portosystemic shunt , 2005, Journal of gastroenterology and hepatology.

[52]  I. Durand-zaleski,et al.  Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia , 2005, Bone Marrow Transplantation.

[53]  D. Borgel,et al.  Sepsis and coagulation , 2005, Current opinion in critical care.

[54]  Joseph A. Smith,et al.  Clinical practice. Treatment of deep-vein thrombosis. , 2005, The Journal of urology.

[55]  S. Olliff,et al.  Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome , 2005, Gut.

[56]  D. Lindhout,et al.  Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia , 2005, Journal of Medical Genetics.

[57]  R. Aggarwal,et al.  Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. , 2005, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[58]  Brian R. Phillips,et al.  Metabolism‐based cyclophosphamide dosing for hematopoietic cell transplant , 2005, Clinical pharmacology and therapeutics.

[59]  J. Roberts,et al.  High incidence of recurrence and hematologic events following liver transplantation for Budd–Chiari syndrome , 2005, Clinical transplantation.

[60]  M. Olausson,et al.  Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia , 2005, Annals of Hematology.

[61]  R. Franchis,et al.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.

[62]  D. Sze,et al.  Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. , 2005, Radiology.

[63]  C. Sempoux,et al.  Extensive ischemic liver necrosis complicating hereditary hemorrhagic telangiectasia: a rare indication for liver transplantation , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[64]  P. Thuluvath,et al.  The Utility of TIPS in the Management of Budd-Chiari Syndrome , 2005, Annals of surgery.

[65]  Chang-jian Liu,et al.  Interventional endovascular treatment for Budd-Chiari syndrome with long-term follow-up. , 2005, Swiss medical weekly.

[66]  D. Valla,et al.  Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis , 2005, British journal of haematology.

[67]  M. Mauro,et al.  Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. , 2005, Journal of vascular and interventional radiology : JVIR.

[68]  Moo-Song Lee,et al.  Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation , 2005, Annals of Hematology.

[69]  V. Paradis,et al.  Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation , 2005, Gut.

[70]  P. Mannucci,et al.  Risk factors for thrombophilia in extrahepatic portal vein obstruction , 2005, Hepatology.

[71]  J. Joh,et al.  Mesenteric and portal vein thrombosis: treated with early initiation of anticoagulation. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[72]  W. Bishop,et al.  Ulcerative Colitis Complicated by Ischemic Colitis and Budd Chiari Syndrome , 2005, Journal of pediatric gastroenterology and nutrition.

[73]  D. Valla.  Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West , 2004 .

[74]  T. Murakami,et al.  Hepatic nodular lesions associated with abnormal development of the portal vein. , 2004, AJR. American journal of roentgenology.

[75]  Yong-fu Zhao,et al.  Management of severe Budd-Chiari syndrome: report of 147 cases. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[76]  S. Olliff,et al.  PTFE‐covered stents improve TIPS patency in Budd‐Chiari syndrome , 2004, Hepatology.

[77]  M. Kugelmas,et al.  Treatment of Budd‐Chiari syndrome in a Liver Transplant Unit, the role of transjugular intrahepatic porto‐systemic shunt and liver transplantation , 2004, Alimentary pharmacology & therapeutics.

[78]  D. Malone,et al.  Acute Budd–Chiari syndrome with liver failure: The experience of a policy of initial interventional radiological treatment using transjugular intrahepatic portosystemic shunt , 2004, Journal of gastroenterology and hepatology.

[79]  R. Porte,et al.  Orthotopic liver transplantation for portosystemic encephalopathy in an adult with congenital absence of the portal vein , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[80]  E. Buscarini,et al.  High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. , 2004, Ultrasound in medicine & biology.

[81]  M. Kotb,et al.  Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study , 2004, Annals of Hematology.

[82]  Jeffrey S. Ginsberg,et al.  Treatment of Deep-Vein Thrombosis , 2004 .

[83]  R. Saxena,et al.  Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. , 2004, American journal of clinical pathology.

[84]  B. Chapuis,et al.  Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[85]  G. McDonald.  Liver disease of uncertain cause , 2004, Bone Marrow Transplantation.

[86]  M. Margaglione,et al.  Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. , 2004, Journal of hepatology.

[87]  X. Dang,et al.  Relations of Budd-Chiari syndrome to prothrombin gene mutation. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[88]  C. Marín,et al.  Congenital hepatic shunts. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[89]  M. Olschewski,et al.  The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. , 2004, Surgery.

[90]  À. Rovira,et al.  Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. , 2004, Journal of hepatology.

[91]  B. Runyon.  Management of adult patients with ascites due to cirrhosis , 2004, Hepatology.

[92]  H. Lee,et al.  Characteristic clinical features of hepatocellular carcinoma associated with Budd–Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma , 2004, European journal of gastroenterology & hepatology.

[93]  F. Rosendaal,et al.  Determinants of survival and the effect of portosystemic shunting in patients with Budd‐Chiari syndrome , 2004, Hepatology.

[94]  R. Manfredi,et al.  Congenital absence of the portal vein associated with focal nodular hyperplasia in the liver in an adult woman , 2004, Abdominal Imaging.

[95]  T. Barbui,et al.  Efficacy and safety of low-dose aspirin in polycythemia vera. , 2004, The New England journal of medicine.

[96]  Cheng-yong Qin,et al.  Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. , 2003, World journal of gastroenterology.

[97]  B. Michałowicz,et al.  Thrombolytic treatment of portal thrombosis. , 2003, Hepato-gastroenterology.

[98]  Jeffrey Tsai,et al.  Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome , 2003, Hepatology.

[99]  G. Hessel,et al.  Growth assessment in children with extra-hepatic portal vein obstruction and portal hypertension. , 2003, Arquivos de gastroenterologia.

[100]  D. Valla,et al.  Clinicopathological forms and prognostic index in Budd-Chiari syndrome. , 2003, Journal of hepatology.

[101]  R. Bañares,et al.  Procedimientos radiológicos intervencionistas, angioplastia y DPPI en el tratamiento del síndrome de Budd-Chiari , 2003 .

[102]  Aniruddha M. Deshpande,et al.  Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.

[103]  G. Kanel,et al.  Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. , 2003, Gastroenterology.

[104]  P. Richardson,et al.  Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. , 2003, Blood.

[105]  T. Barbui,et al.  Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells , 2003, Leukemia.

[106]  H. Deeg,et al.  Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells. , 2003, Blood.

[107]  Paul S. Babyn,et al.  Congenital extrahepatic portosystemic shunts , 2003, Pediatric Radiology.

[108]  T. Asselah,et al.  Portal cavernoma‐associated cholangiopathy: A clinical and MR cholangiography coupled with MR portography imaging study , 2003, Hepatology.

[109]  R. McCuskey,et al.  Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[110]  Z. Xiaoming,et al.  Interventional or semi-interventional treatment for Budd-Chiari syndrome. , 2003, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[111]  A. Burroughs,et al.  TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. , 2003, Journal of hepatology.

[112]  T. Ponchon,et al.  Diagnosis and Treatment of Biliary Obstruction Caused by Portal Cavernoma , 2003, Endoscopy.

[113]  A. Nagler,et al.  Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation: myeloablation with reduced toxicity. , 2003, Experimental hematology.

[114]  M. Manns,et al.  Sonographic criteria for the diagnosis of hepatic involvement in hereditary hemorrhagic telangiectasia (HHT) , 2003, Hepatology.

[115]  A. Bosy-Westphal,et al.  Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. , 2003, The American journal of clinical nutrition.

[116]  Ke-qiang Xu,et al.  Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. , 2003, Chinese medical journal.

[117]  T. Gooley,et al.  Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. , 2003, Blood.

[118]  E. Bandinelli,et al.  [Thrombophilic disorders in children and adolescents with portal vein thrombosis]. , 2003, Jornal de pediatria.

[119]  V. Vilgrain,et al.  Arterial and portal circulation and parenchymal changes in Budd‐Chiari syndrome: A study in 17 explanted livers , 2003, Hepatology.

[120]  D. Valla,et al.  Budd-Chiari syndrome: a review by an expert panel. , 2003, Journal of hepatology.

[121]  J. Wyatt,et al.  The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia , 2003, Histopathology.

[122]  R. Superina,et al.  Surgical restoration of portal flow corrects procoagulant and anticoagulant deficiencies associated with extrahepatic portal vein thrombosis. , 2003, The Journal of pediatrics.

[123]  M. Prins,et al.  Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism , 2002, Annals of Internal Medicine.

[124]  William M. Lee,et al.  Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States , 2002, Annals of Internal Medicine.

[125]  Allen R. Chen,et al.  Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. , 2002, Blood.

[126]  A. Mcmillan,et al.  Hepatic Venoocclusive Disease in Blood and Bone Marrow Transplantation in Children and Young Adults: Incidence, Risk Factors, and Outcome in a Cohort of 241 Patients , 2002, Journal of pediatric hematology/oncology.

[127]  A. Westfall,et al.  A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[128]  G. Klintmalm,et al.  Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders1 , 2002, Transplantation.

[129]  Aytemiz Gurgey,et al.  PAI‐1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs , 2002, American journal of hematology.

[130]  M. Remberger,et al.  Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. , 2002, Blood.

[131]  J. Niland,et al.  Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[132]  G. M. Gulzar,et al.  Endoscopic ligation compared with sclerotherapy for bleeding esophageal varices in children with extrahepatic portal venous obstruction , 2002, Hepatology.

[133]  V. Vilgrain,et al.  Focal nodular hyperplasia inducing hepatic vein obstruction. , 2002, AJR. American journal of roentgenology.

[134]  S. Uemoto,et al.  A Successful Liver Transplantation for Refractory Hepatic Veno‐Occlusive Disease Originating from Cord Blood Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[135]  Hong-ling Hao,et al.  Hyperhomocysteinemia and the MTHFR C677T mutation in Budd‐Chiari syndrome , 2002, American journal of hematology.

[136]  N. Lassau,et al.  Prognostic value of doppler-ultrasonography in hepatic veno-occlusive disease: A Study of 71 Children , 2002, Transplantation.

[137]  M. Margaglione,et al.  Portal Vein Thrombosis after Variceal Endoscopic Sclerotherapy in Cirrhotic Patients: Role of Genetic Thrombophilia , 2002, Endoscopy.

[138]  D. Valla,et al.  Is surgical portosystemic shunt the treatment of choice in Budd-Chiari syndrome? , 2002, Acta gastro-enterologica Belgica.

[139]  M. Orloff,et al.  Bleeding esophagogastric varices from extrahepatic portal hypertension: 40 years' experience with portal-systemic shunt. , 2002, Journal of the American College of Surgeons.

[140]  R. D. de Knegt,et al.  Long‐term effect of treatment of acute Budd‐Chiari syndrome with a transjugular intrahepatic portosytemic shunt , 2002, Hepatology.

[141]  Le-Xin Wang,et al.  Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. , 2002, International journal of cardiology.

[142]  Ha Yeon Lee,et al.  A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[143]  A. Ba-Ssalamah,et al.  Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. , 2002, Journal of vascular and interventional radiology : JVIR.

[144]  G. McDonald,et al.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.

[145]  K. Okuda.  Inferior Vena Cava Thrombosis at Its Hepatic Portion (Obliterative Hepatocavopathy) , 2002, Seminars in liver disease.

[146]  J. Rodés,et al.  TIPS is a useful long‐term derivative therapy for patients with Budd‐Chiari syndrome uncontrolled by medical therapy , 2002, Hepatology.

[147]  Y. Chawla,et al.  Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction , 2001, American Journal of Gastroenterology.

[148]  G. Espinosa,et al.  Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome: Clinical and Immunologic Characteristics of 43 Patients , 2001, Medicine.

[149]  A. Ayav,et al.  Acute mesenteric venous thrombosis: case for nonoperative management. , 2001, Journal of vascular surgery.

[150]  D. Mohanty,et al.  Hereditary thrombophilia as a cause of Budd‐Chiari syndrome: A study from Western India , 2001, Hepatology.

[151]  Y. Bertrand,et al.  Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens , 2001, Bone Marrow Transplantation.

[152]  K. Batts,et al.  The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. , 2001, Journal of hepatology.

[153]  B. De,et al.  Management of the Budd-Chiari syndrome by balloon cavoplasty. , 2001, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[154]  J. Cameron,et al.  Budd-Chiari Syndrome: Current Management Options , 2001, Annals of surgery.

[155]  J. Izbicki,et al.  Hepatic involvement in hereditary hemorrhagic telangiectasia: An unusual indication for liver transplantation , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[156]  R. Aggarwal,et al.  Functional protein C and anti-cardiolipin antibody in children with portal vein thrombosis. , 2001, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[157]  D. Valla,et al.  Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. , 2001, Gastroenterology.

[158]  D. Valla,et al.  Factor V Leiden related Budd-Chiari syndrome , 2001, Gut.

[159]  S. Howard,et al.  Hepatic veno-occlusive disease in children undergoing bone-marrow transplantation: usefulness of sonographic findings , 2001, Pediatric Radiology.

[160]  M. Margaglione,et al.  High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis , 2001, American Journal of Gastroenterology.

[161]  T. Barbui,et al.  Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study , 2000, British journal of haematology.

[162]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study , 2000, British journal of haematology.

[163]  R. Junker,et al.  Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group. , 2000 .

[164]  F R Rosendaal,et al.  Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. , 2000, Blood.

[165]  M. Geisinger,et al.  Surgical shunts and TIPS for variceal decompression in the 1990s. , 2000, Surgery.

[166]  D. Jain,et al.  Liver disease in patients with hereditary hemorrhagic telangiectasia. , 2000, The New England journal of medicine.

[167]  D. Valla,et al.  Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy , 2000, Hepatology.

[168]  K. Emerk,et al.  Protective effect of defibrotide on perfusion induced endothelial damage. , 2000, Thrombosis research.

[169]  J. Ramage,et al.  Clinical features, diagnosis and outcome of acute portal vein thrombosis. , 2000, QJM : monthly journal of the Association of Physicians.

[170]  L. Palazzo,et al.  Biliary varices on endoscopic ultrasonography: clinical presentation and outcome. , 2000, Endoscopy.

[171]  J. Gieseke,et al.  Detection of thrombosis in the portal venous system: comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography. , 2000, Radiology.

[172]  U. Settmacher,et al.  Venous complications after orthotopic liver transplantation , 2000, Clinical transplantation.

[173]  K. Ohashi,et al.  The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno‐occlusive disease after stem cell transplantation , 2000, American journal of hematology.

[174]  D. Valla,et al.  Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. , 2000, Journal of hepatology.

[175]  H. Bismuth,et al.  Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation , 2000, Bone Marrow Transplantation.

[176]  J. Wilde,et al.  Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? , 2000, Gut.

[177]  E. Fibach,et al.  Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome. , 2000, Journal of hepatology.

[178]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[179]  D. Valla,et al.  Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors , 2000, Hepatology.

[180]  R. Saad,et al.  Portal vein thrombosis following splenectomy , 2000, The British journal of surgery.

[181]  G. Kanel,et al.  Support of sinusoidal endothelial cell glutathione prevents hepatic veno‐occlusive disease in the rat , 2000, Hepatology.

[182]  M. Margaglione,et al.  Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis , 2000, Hepatology.

[183]  Y. Chawla,et al.  Coagulation abnormalities in idiopathic portal venous thrombosis , 1999, Journal of gastroenterology and hepatology.

[184]  M. Margaglione,et al.  Anticardiolipin antibodies in patients with liver disease , 1999, American Journal of Gastroenterology.

[185]  Jung Lim Lee,et al.  Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[186]  Y. Chawla,et al.  Duplex Doppler sonography in patients with Budd–Chiari syndrome , 1999, Journal of gastroenterology and hepatology.

[187]  D. Valla,et al.  Outcome of Budd‐Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting , 1999, Hepatology.

[188]  G. Everson,et al.  Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. , 1999, Journal of vascular and interventional radiology : JVIR.

[189]  K. Sullivan,et al.  Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10‐year follow‐up , 1999, Hepatology.

[190]  D. Mitchell,et al.  Budd-Chiari syndrome: hepatic venous obstruction by an elevated diaphragm , 1999, Abdominal Imaging.

[191]  S. Olliff,et al.  Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting , 1999, Gut.

[192]  S. Singhal,et al.  Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD) , 1999, Bone Marrow Transplantation.

[193]  D. Ganger,et al.  Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. , 1999, The American journal of gastroenterology.

[194]  K. Horibe,et al.  Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors , 1998, Bone Marrow Transplantation.

[195]  A. Gratwohl,et al.  Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow Transplantation , 1998 .

[196]  G. Ehninger,et al.  Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation , 1998, Bone Marrow Transplantation.

[197]  D. Neuberg,et al.  Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. , 1998, Blood.

[198]  P. Mathur,et al.  Portai hypertension in North Indian children , 1998, Indian journal of pediatrics.

[199]  N. Callander,et al.  Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation , 1998, Annals of Internal Medicine.

[200]  R. Aggarwal,et al.  Significance of elevated igg anticardiolipin antibody levels in patients with budd-chiari syndrome , 1998, American Journal of Gastroenterology.

[201]  D. Valla,et al.  Post-traumatic membranous obstruction of the inferior vena cava associated with a hypercoagulable state. , 1998, Journal of hepatology.

[202]  S. Sarin,et al.  Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management , 1998, The British journal of surgery.

[203]  I. Wanless,et al.  Pathology of the liver in budd‐chiari syndrome: Portal vein thrombosis and the histogenesis of veno‐centric cirrhosis, veno‐portal cirrhosis, and large regenerative nodules , 1998, Hepatology.

[204]  F. Vleggaar,et al.  Endoscopic sclerotherapy for bleeding oesophagogastric varices secondary to extrahepatic portal vein obstruction in an adult Caucasian population , 1998, European journal of gastroenterology & hepatology.

[205]  J. Bourhis,et al.  Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients. , 1997, Radiology.

[206]  M. Schwartz,et al.  Reassessing the role of medical therapy in the management of hepatic vein thrombosis. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[207]  M. Wolf,et al.  Protein C, protein S and antithrombin III in children with portal vein obstruction. , 1997, Journal of hepatology.

[208]  E. Elias,et al.  Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. , 1997, Gut.

[209]  N. Ueno,et al.  Color Doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein , 1997, Journal of clinical ultrasound : JCU.

[210]  S. Mirvis,et al.  Budd-Chiari syndrome resulting from intrahepatic IVC compression secondary to blunt hepatic trauma. , 1997, Clinical radiology.

[211]  Y. Bayraktar,et al.  Budd-Chiari syndrome: a common complication of Behçet's disease. , 1997, The American journal of gastroenterology.

[212]  E. Elias,et al.  Poor prognosis and limited therapeutic options in patients with Budd‐Chiari syndrome and portal venous system thrombosis , 1997, European journal of gastroenterology & hepatology.

[213]  W. Rosse,et al.  The natural history of paroxysmal nocturnal hemoglobinuria. , 1997, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

[214]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. , 1997, Blood.

[215]  D. Valla,et al.  Hepatic venous outflow block caused by short‐length hepatic vein stenoses , 1997, Hepatology.

[216]  J. Herrero,et al.  Interventional therapeutic techniques in Budd-Chiari syndrome , 1997, CardioVascular and Interventional Radiology.

[217]  Jung Lim Lee,et al.  Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. , 1997, Blood.

[218]  C. Lamers,et al.  Hepatic vein stenting for Budd-Chiari syndrome. , 1997, The American journal of gastroenterology.

[219]  M. Tublin,et al.  Benign and malignant portal vein thrombosis: differentiation by CT characteristics. , 1997, AJR. American journal of roentgenology.

[220]  A. Saraya,et al.  Multilineage hempoietic stem cell defects in Budd Chiari syndrome , 1997 .

[221]  S. Wren,et al.  The role of anticoagulation in pylephlebitis. , 1996, American journal of surgery.

[222]  J. Griffith,et al.  Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. , 1996, Clinical radiology.

[223]  P. Ljungman,et al.  Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation. , 1996, Transplantation.

[224]  L. DeLeve.  Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation , 1996, Hepatology.

[225]  K. Brown,et al.  Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. , 1996, Radiology.

[226]  P. Ljungman,et al.  Aspects concerning busulfan pharmacokinetics and bioavailability. , 1996, Leukemia & lymphoma.

[227]  D. Valla,et al.  Budd-Chiari syndrome associated with 5q deletion and hypereosinophilia. , 1996, Journal of clinical gastroenterology.

[228]  M. Cairo,et al.  Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. , 1996, Bone marrow transplantation.

[229]  D. Agrawal,et al.  Management of idiopathic Budd-Chiari syndrome with primary stent placement: early results. , 1996, Journal of vascular and interventional radiology : JVIR.

[230]  S. Chierchia,et al.  Drug‐induced in vitro inhibition of neutrophil‐endothelial cell adhesion , 1996, British journal of pharmacology.

[231]  R. Arora,et al.  Balloon dilatation of inferior vena cava stenosis in Budd-Chiari syndrome. , 1996, The Journal of the Association of Physicians of India.

[232]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[233]  R. Storb,et al.  Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels. , 1996, Bone marrow transplantation.

[234]  E. Estey,et al.  Treatment of newly‐diagnosed acute myelogenous leukaemia in patients aged 80 years and above , 1996, British journal of haematology.

[235]  N. Kaplowitz,et al.  Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease , 1996, Hepatology.

[236]  K. Okuda,et al.  Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal , 1996, Journal of gastroenterology and hepatology.

[237]  P. Ljungman,et al.  No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation. , 1995, Transplantation proceedings.

[238]  D. Dooley,et al.  Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[239]  J. Odell,et al.  Surgical repair in children with the Budd-Chiari syndrome. , 1995, The Journal of thoracic and cardiovascular surgery.

[240]  D. Valla,et al.  Small intestinal stricture complicating superior mesenteric vein thrombosis. A study of three cases. , 1995, Gut.

[241]  A. Chak,et al.  Duplex Doppler endosonography in the diagnosis of splenic vein, portal vein, and portosystemic shunt thrombosis. , 1995, Gastrointestinal endoscopy.

[242]  E. Masini,et al.  Polydeoxyribonucleotides and nitric oxide release from guinea‐pig hearts during ischaemia and reperfusion , 1995, British journal of pharmacology.

[243]  J. Brink,et al.  Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. , 1995, AJR. American journal of roentgenology.

[244]  H. Sevestre,et al.  Thrombose portale et cirrhose : interet de la ponction-biopsie echoguidee du thrombus , 1995 .

[245]  J. Butany,et al.  Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis) , 1995, Hepatology.

[246]  M. Gebel,et al.  Which is the best surgery for budd‐chiari syndrome: Venous decompression or liver transplantation? a single‐center experience with 50 patients , 1995, Hepatology.

[247]  T. Kofler,et al.  Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. , 1995, Transplantation.

[248]  B. Giusti,et al.  Defibrotide® Reduces Monocyte PAI-2 and Procoagulant Activity , 1995, Seminars in thrombosis and hemostasis.

[249]  B. Portmann,et al.  Hepatic venous outflow obstruction in patients with polycystic liver disease: pathogenesis and treatment. , 1995, Gut.

[250]  W. Bechstein,et al.  Liver transplantation for Budd-Chiari syndrome. , 1994, Transplantation proceedings.

[251]  G. Morgan,et al.  Congenital absence of the portal vein: two cases and a proposed classification system for portasystemic vascular anomalies. , 1994, Journal of pediatric surgery.

[252]  G. McDonald,et al.  Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms , 1994, Hepatology.

[253]  V. Vilgrain,et al.  The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. , 1994, Gastroenterology.

[254]  L. Bianchi,et al.  Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. , 1994, Blood.

[255]  D. Valla,et al.  Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. , 1994, Surgery.

[256]  J. Krige,et al.  A 15‐Year Experience of Injection Sclerotherapy in Adult Patients with Extrahepatic Portal Venous Obstruction , 1994, Annals of surgery.

[257]  Y. Chawla,et al.  Hepatic Outflow Obstruction (Budd‐Chiari Syndrome) Experience with 177 Patients and a Review of the Literature , 1994, Medicine.

[258]  K. Reddy,et al.  Management of hepatic venous outflow obstruction , 1993, The Lancet.

[259]  G. Anderson,et al.  Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[260]  A. Duerinckx,et al.  Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. , 1993, AJR. American journal of roentgenology.

[261]  L. Grochow.  Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens. , 1993, Seminars in oncology.

[262]  D. Shen,et al.  A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation , 1993, British journal of haematology.

[263]  D. Valla,et al.  Bacteroides bacteraemia of undetermined origin: strong association with portal vein thrombosis and cryptogenic pylephlebitis , 1993 .

[264]  C. Tondo,et al.  Nitric Oxide and Prostacyclin Influence Coronary Vasomotor Tone in Perfused Rabbit Heart and Modulate Endothelin‐1 Activity , 1993, Journal of cardiovascular pharmacology.

[265]  M. Mantovani,et al.  Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. , 1993, European journal of pharmacology.

[266]  S. Zargar,et al.  Biliary abnormalities associated with extrahepatic portal venous obstruction , 1993, Hepatology.

[267]  G. McDonald,et al.  Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients , 1993, Annals of Internal Medicine.

[268]  T. Starzl,et al.  The incidence of portal vein thrombosis at liver transplantation , 1992, Hepatology.

[269]  M. Blostein,et al.  A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. , 1992, Bone marrow transplantation.

[270]  C. Higano,et al.  Venocclusive disease of the liver: prospective study of US evaluation. , 1992, Radiology.

[271]  J. H. Park,et al.  Membranous obstruction of the inferior vena cava: comparison of findings at sonography, CT, and venography. , 1992, AJR. American journal of roentgenology.

[272]  T. Cheng,et al.  Nonoperative treatment of membranous obstruction of the inferior vena cava by percutaneous balloon transluminal angioplasty. , 1992, American heart journal.

[273]  G. Vassal,et al.  Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. , 1992, Bone marrow transplantation.

[274]  H. Klöcking.  Acute t-PA release by defibrotide. , 1992, Thrombosis research.

[275]  G. Klintmalm,et al.  Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. , 1992, Surgery, gynecology & obstetrics.

[276]  M. Labopin,et al.  Prophylactic heparin does not prevent liver veno‐occlusive disease following autologous bone marrow transplantation , 1991, European journal of haematology.

[277]  H. Bismuth,et al.  Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. , 1991, Annals of surgery.

[278]  A. Klein,et al.  Percutaneous intervention in portosystemic shunts in Budd-Chiari syndrome. , 1991, Journal of vascular and interventional radiology : JVIR.

[279]  N Ragavendra,et al.  Diagnosis of portal vein thrombosis: value of color Doppler imaging. , 1991, AJR. American journal of roentgenology.

[280]  J. Lau,et al.  Hepatology , 1999, Digestive Disease Interventions.

[281]  C. Legnani,et al.  Modulation of arachidonate metabolite generation in human blood by oral defibrotide. , 1991, Arzneimittel-Forschung.

[282]  R. Lakhoua,et al.  [Budd-Chiari syndrome in children. Apropos of 7 cases]. , 1991, Archives francaises de pediatrie.

[283]  T. Hohlfeld,et al.  Stimulation of Prostacyclin Synthesis by Defibrotide: Improved Contractile Rocovery from Myocardial “Stunning” , 1991, Journal of cardiovascular pharmacology.

[284]  H. Guan.  [Diagnosis and treatment of membraneous obstruction of the inferior vena cava]. , 1990, Zhonghua wai ke za zhi [Chinese journal of surgery].

[285]  N. Moat,et al.  Diagnosis and management of mesenteric infarction , 1990, The British journal of surgery.

[286]  F. Appelbaum,et al.  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. , 1990, Blood.

[287]  S. Furui,et al.  Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents. , 1990, Radiology.

[288]  G. McDonald,et al.  A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. , 1990, Bone marrow transplantation.

[289]  R. Yamada,et al.  Percutaneous transluminal angioplasty in segmental obstruction of the hepatic inferior vena cava: Long-term results , 1990, CardioVascular and Interventional Radiology.

[290]  W. Millikan,et al.  Angioplasty for long-term treatment of patients with Budd-Chiari syndrome. , 1990, AJR. American journal of roentgenology.

[291]  A. M. Lefer,et al.  Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[292]  R. Busuttil,et al.  Budd-Chiari Syndrome: The Results of Duplex and Color Doppler Imaging , 1989, AJR. American journal of roentgenology.

[293]  F. Brunelle,et al.  Budd-Chiari syndrome in children: report of 22 cases. , 1988, The Journal of pediatrics.

[294]  R. Calne,et al.  Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome. , 1988, Surgery, gynecology & obstetrics.

[295]  W. Millikan,et al.  Management of Variceal Bleeding in Patients with Noncirrhotic Portal Vein Thrombosis , 1988, Annals of surgery.

[296]  D. Dhumeaux,et al.  Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. , 1988, International journal of radiation oncology, biology, physics.

[297]  D. Valla,et al.  Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. , 1988, Gastroenterology.

[298]  J. B. Simon,et al.  Response to steroids in Budd-Chiari syndrome caused by idiopathic granulomatous venulitis. , 1988, Gastroenterology.

[299]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[300]  P. Sahni,et al.  Operations for portal hypertension due to extrahepatic obstruction: results and 10 year follow up. , 1987, British medical journal.

[301]  D. Dhumeaux,et al.  Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria , 1987 .

[302]  D. Dhumeaux,et al.  Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. , 1987, Gastroenterology.

[303]  F. Appelbaum,et al.  Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. , 1987, Transplantation.

[304]  R. Gibson,et al.  Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome. , 1987, Gut.

[305]  I. Wanless,et al.  Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. , 1986, Archives of pathology & laboratory medicine.

[306]  D. Valla,et al.  Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. , 1986, Gastroenterology.

[307]  D. Valla,et al.  Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. , 1985, Annals of internal medicine.

[308]  K. Kimura,et al.  Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. , 1985, Gastroenterology.

[309]  Pankaj Sharma,et al.  THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION , 1985, Transplantation.

[310]  I. Wanless,et al.  Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. , 1985, Archives of pathology & laboratory medicine.

[311]  J. Struyven,et al.  Sonographic features of portal vein thrombosis. , 1985, AJR. American journal of roentgenology.

[312]  R. Peters,et al.  Membranous Obstruction of the Inferior Vena Cava in the United States , 1985, Medicine.

[313]  P. Grenier,et al.  Portal thrombosis: dynamic CT features and course. , 1985, Radiology.

[314]  D. Valla,et al.  SUCCESSFUL PREGNANCY AFTER BUDD-CHIARI SYNDROME , 1984, The Lancet.

[315]  W. McDermott,et al.  Budd-Chiari syndrome. Historical and clinical review with an analysis of surgical corrective procedures. , 1984, American journal of surgery.

[316]  B. Kahan,et al.  Prolongation of rat kidney allografts by pretransplant administration of donor antigen extract or whole blood transfusion combined with a short course of cyclosporine. , 1983, Transplantation.

[317]  R. Yamada,et al.  Segmental obstruction of the hepatic inferior vena cava treated by transluminal angioplasty. , 1983, Radiology.

[318]  G. Marchal,et al.  Early diagnosis of Budd-Chiari syndrome by computed tomography and ultrasonography: report of five cases. , 1983, Gastroenterology.

[319]  D. V. Datta,et al.  Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. , 1980, The American journal of medicine.

[320]  S. Sherlock,et al.  The aetiology, presentation and natural history of extra-hepatic portal venous obstruction. , 1979, The Quarterly journal of medicine.

[321]  B. Mcguinness,et al.  Twenty years on. , 1976, British medical journal.

[322]  A. Tavill,et al.  The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. , 1975, Gastroenterology.

[323]  V. d'APUZZO.  RENAL-VEIN THROMBOSIS IN KIDNEY ALLOGRAFTS , 1973 .

[324]  J. Freston,et al.  Vascular radiology in the Budd-Chiari syndrome. , 1967, The British journal of radiology.

[325]  H. Bouissou,et al.  [The Budd-Chiari syndrome in children]. , 1961, Toulouse medical.

[326]  R. Parker.  OCCLUSION OF THE HEPATIC VEINS IN MAN , 1959, Medicine.

[327]  D. Hough,et al.  Abdominal findings in hereditary hemorrhagic telangiectasia: pictorial essay on 2D and 3D findings with isotropic multiphase CT. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[328]  D. Valla,et al.  Long-term portosystemic shunt patency as a determinant of outcome in Budd-Chiari syndrome. , 2007, Journal of hepatology.

[329]  J. Honnorat,et al.  Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: Data from the French-Italian HHT network , 2007, Genetics in Medicine.

[330]  Young Wook Kim,et al.  Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. , 2006, Journal of vascular surgery.

[331]  M. Björck,et al.  Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. , 2006, World journal of gastroenterology.

[332]  R. Egeler,et al.  Intravenous busulfan in children prior to stem cell transplantation: study of pharmacokinetics in association with early clinical outcome and toxicity , 2005, Bone Marrow Transplantation.

[333]  H. Sharif,et al.  MR, CT, and ultrasonography of splanchnic venous thrombosis , 2005, Gastrointestinal Radiology.

[334]  O. Pozler,et al.  [Budd-Chiari syndrome and TIPS--twelve years' experience]. , 2005, Casopis lekaru ceskych.

[335]  J. Pringot,et al.  Hepatic heterogeneity on CT in Budd-Chiari syndrome: Correlation with regional disturbances in portal flow , 2005, Gastrointestinal Radiology.

[336]  R. de Franchis.  Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. , 2005, Journal of hepatology.

[337]  A. Rahmouni,et al.  Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis , 2005, Gastrointestinal Radiology.

[338]  S. Nomura,et al.  Patent ductus venosus in children: a case report and review of the literature. , 2004, Journal of Pediatric Surgery.

[339]  R. Storb,et al.  Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. , 2004, Blood.

[340]  A. Rotondo,et al.  Hereditary hemorrhagic telangiectasia: multi-detector row helical CT assessment of hepatic involvement. , 2004, Radiology.

[341]  S. Olliff,et al.  Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. , 2004, Journal of hepatology.

[342]  L. Grochow,et al.  Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation , 2004, Cancer Chemotherapy and Pharmacology.

[343]  P. Davis,et al.  Budd-Chiari syndrome: Imaging with pathologic correlation , 2004, Abdominal Imaging.

[344]  A. Habr-Gama,et al.  Doppler demonstration of cystic vein dilatation secondary to portal vein thrombosis , 2004, Surgical Endoscopy.

[345]  A. Schulz,et al.  Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention , 2004, Bone Marrow Transplantation.

[346]  B. Bacon,et al.  Budd-Chiari Syndrome and Hepatocellular Carcinoma: A Case Report and Review of the Literature , 2003, American Journal of Gastroenterology.

[347]  W. Tzeng,et al.  CT of small bowel ischemia , 2003, Abdominal Imaging.

[348]  Á. Ponferrada,et al.  [Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome]. , 2003, Gastroenterologia y hepatologia.

[349]  A. Friera,et al.  Congenital and acquired anomalies of the portal venous system. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[350]  D. Valla,et al.  Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents , 2002, European Radiology.

[351]  C. Rossi,et al.  Treatment of vascular complications following liver transplantation: multidisciplinary approach. , 2001, Hepato-gastroenterology.

[352]  M. Colombo,et al.  Nonpercutaneous therapies of hepatocellular carcinoma. , 2001, Hepato-gastroenterology.

[353]  A. Chiesa,et al.  Congenital absence of portal vein with nodular regenerative hyperplasia of the liver , 2000, European Radiology.

[354]  Y. Bayraktar,et al.  The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. , 2000, Journal of clinical gastroenterology.

[355]  M. Gaub,et al.  Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. , 1999, Gastroenterology.

[356]  J. Viale,et al.  Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. , 1999, Gastroenterology.

[357]  A. Gratwohl,et al.  Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. , 1998, Blood.

[358]  P. Ljungman,et al.  Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. , 1998, Blood.

[359]  X. Causse,et al.  [Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients]. , 1997, Gastroenterologie clinique et biologique.

[360]  A. Saraya,et al.  Multilineage hemopoietic stem cell defects in Budd Chiari syndrome. , 1997, Journal of hepatology.

[361]  T. Cheng.  Percutaneous balloon angioplasty for membranous obstruction of inferior vena cava. , 1997, The Journal of cardiovascular surgery.

[362]  B. Langer,et al.  Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. , 1996, American journal of surgery.

[363]  J. Wingard,et al.  Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. , 1996, Hepatology.

[364]  E. Ring,et al.  Percutaneous transhepatic hepatic venography in the delineation and treatment of Budd-Chiari syndrome. , 1996, Journal of vascular and interventional radiology : JVIR.

[365]  H. Sevestre,et al.  [Portal thrombosis and liver cirrhosis. Value of ultrasound-guided puncture-biopsy of the thrombus]. , 1995, Gastroenterologie clinique et biologique.

[366]  H. Iwata,et al.  Epidemiological and clinical features of Budd-Chiari syndrome in Japan. , 1995, Journal of hepatology.

[367]  American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers. , 1995, Gastroenterology.

[368]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[369]  A. Grañena,et al.  Transjugular liver biopsy in BMT. , 1993, Bone marrow transplantation.

[370]  G. Laurent,et al.  Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial. , 1993, Blood.

[371]  F. Appelbaum,et al.  A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. , 1993, Blood.

[372]  G. Mehrotra,et al.  Pyogenic liver abscess causing acute Budd-Chiari syndrome. , 1992, Annals of tropical paediatrics.

[373]  R. Calne,et al.  Liver transplantation for Budd-Chiari syndrome, 1976-1990. , 1991, Annales de chirurgie.

[374]  E. Gluckman,et al.  Role of PGE1 to prevent veno-occlusive disease of the liver after bone marrow transplantation. , 1990, Nouvelle revue francaise d'hematologie.

[375]  J. Ludwig,et al.  Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. , 1990, Mayo Clinic proceedings.

[376]  D. Dallis,et al.  Mesenteric venous thrombosis--1911 to 1984. , 1987, Surgery.

[377]  T. Talamo,et al.  Constrictive pericarditis mimicking Budd-Chiari syndrome. , 1986, The American journal of medicine.